Misoprostol for the termination of pregnancy up to 12 completed weeks of pregnancy

被引:37
作者
Faundes, A. [1 ]
Fiala, C. [1 ]
Tang, O. S. [2 ]
Velasco, A. [3 ]
机构
[1] Gynmed Clin, Vienna, Austria
[2] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Peoples R China
[3] Hosp Eusebio Hernandez, Dept Gynecol & Obstet, Havana, Cuba
关键词
misoprostol alone; medical abortion; effectiveness;
D O I
10.1016/j.ijgo.2007.09.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The aim was to review the current knowledge about the use of misoprostol atone for abortion induction during the first 12 weeks of pregnancy. Publications reporting experiences with misoprostol atone for pregnancy termination within the first 12 weeks of pregnancy were included in the analysis. Vaginal administration of 800 mu g repeated up to three times at 6, 12 or 24 h intervals has an 85% to 90% effectiveness, defined as complete abortion, in most studies. Oral administration is less effective, but sublingual administration at 3-hour interval has the same effectiveness, with more frequent side effects. The oral and sublingual routes appear to be better accepted than vaginal administration. Most studies are limited to the first 9 weeks of pregnancy. The experience on pregnancy termination between 10 and 12 weeks is not yet sufficient for a recommendation. (C) 2007 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S172 / S177
页数:6
相关论文
共 60 条
[11]   Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion [J].
Bugalho, A ;
Faundes, A ;
Jamisse, L ;
Usfa, M ;
Maria, E ;
Bique, C .
CONTRACEPTION, 1996, 53 (04) :243-246
[12]   Termination of pregnancies of <6 weeks gestation with a single dose of 800 μg of vaginal misoprostol [J].
Bugalho, A ;
Mocumbi, S ;
Faúndes, A ;
David, E .
CONTRACEPTION, 2000, 61 (01) :47-50
[13]  
Carbonell J L, 1999, Eur J Contracept Reprod Health Care, V4, P35, DOI 10.3109/13625189909043478
[14]   Oral and vaginal misoprostol 800 μg every 8 h for early abortion [J].
Carbonell, JLL ;
Rodríguez, J ;
Velazco, A ;
Tanda, R ;
Sánchez, C ;
Barambio, S ;
Chami, S ;
Valero, F ;
Marí, J ;
de Vargas, F ;
Salvador, I .
CONTRACEPTION, 2003, 67 (06) :457-462
[15]   Oral methotrexate and vaginal misoprostol for early abortion [J].
Carbonell, JLL ;
Varela, L ;
Velazco, A ;
Cabezas, E ;
Fernández, C ;
Sánchez, C .
CONTRACEPTION, 1998, 57 (02) :83-88
[16]   The use of misoprostol for termination of early pregnancy [J].
Carbonell, JLL ;
Varela, L ;
Velazco, A ;
Fernandez, C .
CONTRACEPTION, 1997, 55 (03) :165-168
[17]   BLOOD-LOSS IN TERMINATION OF EARLY-PREGNANCY BY VACUUM ASPIRATION AND BY COMBINATION OF MIFEPRISTONE AND GEMEPROST [J].
CHAN, YF ;
HO, PC ;
MA, HK .
CONTRACEPTION, 1993, 47 (01) :85-95
[18]  
Chong Yap Seng, 1997, Obstetrics and Gynecology, V90, P703, DOI 10.1016/S0029-7844(97)00275-5
[19]  
Chong YS, 2002, HUM REPROD, V17, P2777, DOI 10.1093/humrep/17.10.2777
[20]   A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion [J].
Creinin, MD ;
Carbonell, JLL ;
Schwartz, JL ;
Varela, L ;
Tanda, R .
CONTRACEPTION, 1999, 59 (01) :11-16